SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 102,300
-700 (-0.68%)
At close: Apr 24, 2026
-2.48% (1Y)
| Market Cap | 8.07T +2.2% |
| Revenue (ttm) | 706.74B +29.1% |
| Net Income | 266.95B +10.9% |
| EPS | 3,408.75 +10.9% |
| Shares Out | 78.31M |
| PE Ratio | 30.22 |
| Forward PE | 30.34 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 131,054 |
| Average Volume | 178,060 |
| Open | 102,700 |
| Previous Close | 103,000 |
| Day's Range | 101,600 - 102,900 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.86 |
| RSI | 51.80 |
| Earnings Date | May 11, 2026 |